Proteostasis Teams Up With Elan In $50M Neurodegenerative Collaboration
This article was originally published in The Pink Sheet Daily
Executive Summary
Irish company will get a 24% stake in the U.S. biotech as part of an R&D collaboration centered around neurodegenerative diseases.